Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Wenger

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Molecular Medicine Today|November 14, 2000
Murine, canine and non-human primate models of Krabbe diseaseD A Wenger
APMIS. Supplementum|January 1, 1993
Research update on lysosomal disorders with special emphasis on metachromatic leukodystrophy and Krabbe diseaseD A Wenger
Advances in Experimental Medicine and Biology|January 1, 1978
Assay of beta-glucosidase and sphingomyelinase for identification of patients and carriers of Gaucher's and Niemann-Pick diseasesD A Wenger
Chemistry and Physics of Lipids|December 1, 1974
Studies on galactosyl ceramide and lactosyl ceramide beta-galactosidaseD A Wenger
Brain & Development|January 1, 1985
Diagnosis of atypical patients with lipid storage diseasesD A Wenger
Archives of Neurology|March 1, 1984
The brain in Gaucher's diseaseD A Wenger
Biochimica Et Biophysica Acta|February 28, 1986
Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblastsS Fujibayashi, D A Wenger
The Journal of Clinical Investigation|July 1, 1982
Diagnosis of metachromatic leukodystrophy, Krabbe disease, and Farber disease after uptake of fatty acid-labeled cerebroside sulfate into cultured skin fibroblastsT Kudoh, D A Wenger
Clinical Genetics|October 1, 1984
Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytesK Inui, D A Wenger
The Journal of Clinical Investigation|November 1, 1983
Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseasesK Inui, D A Wenger
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Molecular Medicine Today|November 14, 2000
Murine, canine and non-human primate models of Krabbe diseaseD A Wenger
APMIS. Supplementum|January 1, 1993
Research update on lysosomal disorders with special emphasis on metachromatic leukodystrophy and Krabbe diseaseD A Wenger
Advances in Experimental Medicine and Biology|January 1, 1978
Assay of beta-glucosidase and sphingomyelinase for identification of patients and carriers of Gaucher's and Niemann-Pick diseasesD A Wenger
Chemistry and Physics of Lipids|December 1, 1974
Studies on galactosyl ceramide and lactosyl ceramide beta-galactosidaseD A Wenger
Brain & Development|January 1, 1985
Diagnosis of atypical patients with lipid storage diseasesD A Wenger
Archives of Neurology|March 1, 1984
The brain in Gaucher's diseaseD A Wenger
Biochimica Et Biophysica Acta|February 28, 1986
Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblastsS Fujibayashi, D A Wenger
The Journal of Clinical Investigation|July 1, 1982
Diagnosis of metachromatic leukodystrophy, Krabbe disease, and Farber disease after uptake of fatty acid-labeled cerebroside sulfate into cultured skin fibroblastsT Kudoh, D A Wenger
Clinical Genetics|October 1, 1984
Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytesK Inui, D A Wenger
The Journal of Clinical Investigation|November 1, 1983
Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseasesK Inui, D A Wenger
Pageof 16